Results 281 to 290 of about 38,554 (353)

Late‐Onset Third Degree Atrioventricular Block in Adult With Surgically Corrected Ebstein Anomaly: A Case Report

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Late‐onset third‐degree atrioventricular (AV) block is a rare life‐threatening complication that may develop years after surgical correction of Ebstein anomaly. Effective management depends on routine cardiac monitoring and timely intervention with an epicardial permanent pacemaker.
Bishal Kumar Yadav, Bishal Sigdel, Bishal Mandal, Abhishek Mahato, Bishal Basnet, Samir Yadav, Anil Bhattarai   +6 more
wiley   +1 more source

Clinical outcomes after ventricular tachycardia ablation with or without induction. [PDF]

Heart Rhythm O2
Freedman BL, Yang S, Waks JW, Locke A, Maher TR, d'Avila A.   +5 more
europepmc   +1 more source

Diving deeper: Essential role of advanced ventricular tachycardia ablation techniques in hypertrophic cardiomyopathy

Douglas Darden, Dhanunjaya Lakkireddy
openalex   +1 more source

Cardiac MRI Across ESC Guidance in the Last Decade

Clinical Cardiology, Volume 49, Issue 5, May 2026.
CMR: bridging clinical challenges to guideline solutions. Four panels summarise the role of cardiovascular magnetic resonance (CMR) in ESC guidance. Abbreviations: CMR = cardiovascular magnetic resonance. ESC = European Society of Cardiology. MINOCA = myocardial infarction with non‐obstructive coronary arteries. RV = right ventricle.
Alexander Gall, Nicholas Sawh, Rui Li, Peter P. Swoboda, Andrew J. Swift, Gareth Matthews, Pankaj Garg   +6 more
wiley   +1 more source

Preprocedural imaging guiding ventricular tachycardia ablation in structural heart disease. [PDF]

J Arrhythm
Nunes-Ferreira A, Brito J, Cortez-Dias N, da Lima da Silva G, Pinto FJ, de Sousa J.   +5 more
europepmc   +1 more source

Ventricular tachycardia recurrence after catheter ablation in non-ischemic cardiomyopathy with mildly to moderately reduced ejection fraction

Boldizsar Kovacs, Leon Dinshaw, A Marco Del Castillo, Christiane Jungen, Stefan Kurath-Koller, Stefan Stojković, Francesco Santoro, Giacomo Mugnai, Laura Perrotta, Rachel M.A. ter Bekke, Kevin Vernooy, Paul G.A. Volders, Bert Vandenberk   +12 more
openalex   +1 more source

Efficacy and Safety of Catheter Ablation for Atrial Arrhythmias in Solid Organ Transplant Recipients: A Single‐Center Experience

Clinical Cardiology, Volume 49, Issue 5, May 2026.
Catheter ablation for complex atrial arrhythmias in solid organ transplant recipients is feasible using contemporary techniques, with arrhythmia‐free survival and periprocedural complication rates comparable to matched non‐transplant controls. ABSTRACT Introduction Atrial arrhythmias are common among solid organ transplant recipients and independently ...
Piotr Gardziejczyk, Martyna Skrzyńska‐Kowalczyk, Marta Skowrońska, Ewa Wlazłowska‐Struzik, Pawel Szymkiewicz, Piotr Pruszczyk, Jakub Baran   +6 more
wiley   +1 more source

Hydrodissection for pericardial adhesion in percutaneous epicardial ventricular tachycardia ablation. [PDF]

J Arrhythm
Onishi Y, Asano T, Arai S, Nakamura Y, Shinke T.   +4 more
europepmc   +1 more source

Genotype–Phenotype Discordance in Cardiomyopathies: Pathophysiology, Clinical Expression, and Therapeutic Considerations

Health Science Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Cardiomyopathies encompass a spectrum of myocardial disorders often attributed to underlying genetic mutations. However, genotype–phenotype discordance where the genetic profile does not align with the expected clinical presentation poses significant diagnostic, prognostic, and therapeutic challenges.
Abubakar Nazir, Atif Hussain Sarwar, Rameen Nazar, Sarim Hassan Shahab, Sumera Manan, Hafsa Rafique, Ahsan Talal Khan, Abdalhakim Shubietah, Syed Rafay Hussain Zaidi, Behram Khan   +9 more
wiley   +1 more source

Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB

JIMD Reports, Volume 67, Issue 3, May 2026.
ABSTRACT Mucopolysaccharidosis Type IV is a multisystem lysosomal storage disease characterized by severe skeletal dysplasia resulting from impaired degradation of the glycosaminoglycans keratan sulfate and chondroitin‐6‐sulfate. The condition is classified into Types A and B based on the underlying enzyme deficiency.
Mark Wijnen, Evert F. S. van Velsen, J. Gert‐Jan Milhous, Esmee Oussoren, Bram C. J. van der Eerden, Margreet A. E. M. Wagenmakers   +5 more
wiley   +1 more source